Home › Calculator › CYTK Dividend Calculator 2026
CYTK Dividend Calculator 2026
No dividendHealthcareCytokinetics, Incorporated · NASDAQ
Price: $61.23 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
CYTK is not a dividend-focused stock
CYTK pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
CYTK Dividend Yield
Cytokinetics, Incorporated (CYTK) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When CYTK pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About Cytokinetics, Incorporated (CYTK) — Dividend Analysis 2026
Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.
CYTK Dividend & DRIP — Frequently Asked Questions
Does CYTK pay a dividend?
No. Cytokinetics, Incorporated (CYTK) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of CYTK?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does CYTK have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. CYTK has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to CYTK
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full CYTK DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open CYTK position with:
🌍 CYTK Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold CYTK.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 CYTK Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 CYTK Dividend Payment Schedule
CYTK pays quarterly — 4 times per year. Ex-div: —.
📊 CYTK vs Healthcare Benchmarks
How CYTK compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CYTK sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ CYTK Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| M-Exempt | 2026-10-12 | 7,500 | $10.60 | $79.5K | ||
| Sale | 2026-10-12 | 7,500 | $62.88 | $471.6K | ||
| M-Exempt | 2026-10-12 | 7,500 | $10.60 | $79.5K | ||
| M-Exempt | 2026-10-06 | 3,500 | $7.80 | $27.3K | ||
| Sale | 2026-10-06 | 3,500 | $61.38 | $214.8K | ||
| M-Exempt | 2026-10-06 | 3,500 | $7.80 | $27.3K | ||
| M-Exempt | 2026-09-28 | 7,500 | $10.60 | $79.5K | ||
| Sale | 2026-09-28 | 7,500 | $65.46 | $490.9K | ||
| M-Exempt | 2026-09-28 | 7,500 | $10.60 | $79.5K | ||
| M-Exempt | 2026-09-22 | 3,500 | $7.80 | $27.3K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Peer Group
Similar companies in the same sectorCompare CYTK with peers: CYTK vs ABVX · CYTK vs AXSM · CYTK vs CORT
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where CYTK earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CYTK dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Cytokinetics, Incorporated (CYTK) is currently trading at $61.23, 31% below its 52-week high. It does not currently pay a regular dividend.
Does CYTK Pay a Dividend? Cytokinetics, Incorporated Dividend Status
Cytokinetics, Incorporated (CYTK) is a healthcare stock trading at $61.23. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest CYTK News
LiveProjected your CYTK DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.